Skip to content
Longterm Wiki

Eradavir — Influenza Treatment RCT

grantVerified

Metadata

Source Tablegrants
Source IDhRWZFQEQAr
Descriptionto Eradavir, USD 250000, 2025-03
Source URLcoefficientgiving.org/funds/
ParentCoefficient Giving
Children
CreatedMar 12, 2026, 5:54 AM
UpdatedMar 22, 2026, 2:59 AM
SyncedMar 19, 2026, 8:57 PM

Record Data

idhRWZFQEQAr
organizationIdCoefficient Giving(organization)
granteeIdEradavir
orgEntityIdCoefficient Giving(organization)
orgDisplayName
granteeEntityId
granteeDisplayNameEradavir
nameEradavir — Influenza Treatment RCT
amount250000
currencyUSD
period
date2025-03
status
sourcecoefficientgiving.org/funds/
notes[Scientific Research] Open Philanthropy recommended an investment of $250,000 in Eradavir to support a randomized controlled trial of a drug for treating influenza. The team’s novel antiviral approach links two haptens that recruit the immune system to an already approved influenza antiviral, zanami
programIdB4pZkOtjSk
dataSourceId

Source Check Verdicts

confirmed95% confidence

Last checked: 4/29/2026

1 → confirmed

Debug info

Thing ID: hRWZFQEQAr

Source Table: grants

Source ID: hRWZFQEQAr

Parent Thing ID: sid_ULjDXpSLCI